Can a Sugar-Tracking scan predict cancer treatment success?
NCT ID NCT01996046
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looks at whether a special type of PET/CT scan (called FDG PET/CT) can help doctors see how well hormone therapy is working in breast cancer that has spread to the bones. About 75 adults with estrogen receptor-positive breast cancer and bone metastases will get the scan before starting a new hormone treatment, then again at 4 weeks and 12 weeks after. The goal is to see if changes in the scan can predict how long the cancer stays under control and overall survival.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
FDG PET/CT scan (a special imaging test using a radioactive sugar tracer)
What this could lead to
If successful, this could help doctors use PET/CT scans to more accurately predict how well hormone therapy is working in breast cancer that has spread to bones.
What could go wrong
This is an early-stage imaging study with only 75 participants, so results may not apply to all patients. The scan's ability to predict long-term outcomes is still unproven.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BONE METASTASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Pennsylvania Hospital
Philadelphia, Pennsylvania, 19104, United States